Patrick Griffin

832 total citations
20 papers, 431 citations indexed

About

Patrick Griffin is a scholar working on Gastroenterology, Surgery and Clinical Psychology. According to data from OpenAlex, Patrick Griffin has authored 20 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Gastroenterology, 11 papers in Surgery and 2 papers in Clinical Psychology. Recurrent topics in Patrick Griffin's work include Gastrointestinal motility and disorders (12 papers), Congenital gastrointestinal and neural anomalies (7 papers) and Gastroesophageal reflux and treatments (4 papers). Patrick Griffin is often cited by papers focused on Gastrointestinal motility and disorders (12 papers), Congenital gastrointestinal and neural anomalies (7 papers) and Gastroesophageal reflux and treatments (4 papers). Patrick Griffin collaborates with scholars based in United States, Ireland and Slovenia. Patrick Griffin's co-authors include Sanjiv Chopra, Laura Barrow, Kunwar Shailubhai, Leslie Magnus, William Koltun, Philip B. Miner, Robert A. Crozier, Richard A. Krause, Ronald Fogel and Anh Nguyen and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and The American Journal of Gastroenterology.

In The Last Decade

Patrick Griffin

19 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Griffin United States 9 299 229 62 34 31 20 431
Elizabeth Barba Spain 11 271 0.9× 135 0.6× 90 1.5× 69 2.0× 37 1.2× 30 393
Cyriaque Bon France 10 214 0.7× 143 0.6× 71 1.1× 23 0.7× 21 0.7× 20 351
James E. Mayle United States 6 363 1.2× 260 1.1× 127 2.0× 41 1.2× 29 0.9× 10 606
Ciaran Judge Ireland 7 180 0.6× 117 0.5× 59 1.0× 20 0.6× 30 1.0× 18 387
Sara Linker Nord United States 7 193 0.6× 183 0.8× 77 1.2× 23 0.7× 54 1.7× 12 399
Florian Abel United States 8 178 0.6× 75 0.3× 100 1.6× 28 0.8× 33 1.1× 16 325
Kenya Jackson United States 8 459 1.5× 190 0.8× 218 3.5× 46 1.4× 28 0.9× 14 544
Navya D. Kanuri United States 9 195 0.7× 139 0.6× 55 0.9× 17 0.5× 130 4.2× 17 485
G. Lindsay McCrea United States 6 310 1.0× 230 1.0× 66 1.1× 15 0.4× 18 0.6× 9 423
Yukie Kohata Japan 10 393 1.3× 321 1.4× 69 1.1× 22 0.6× 21 0.7× 15 467

Countries citing papers authored by Patrick Griffin

Since Specialization
Citations

This map shows the geographic impact of Patrick Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Griffin more than expected).

Fields of papers citing papers by Patrick Griffin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Griffin. The network helps show where Patrick Griffin may publish in the future.

Co-authorship network of co-authors of Patrick Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Griffin. A scholar is included among the top collaborators of Patrick Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Griffin. Patrick Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timulák, Ladislav, Craig Chigwedere, Charlotte Wilson, et al.. (2022). A comparison of emotion-focused therapy and cognitive-behavioral therapy in the treatment of generalized anxiety disorder: Results of a feasibility randomized controlled trial.. Psychotherapy. 59(1). 84–95. 22 indexed citations
2.
Waldman, Scott A., et al.. (2019). Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation. Clinical and Translational Gastroenterology. 10(7). e00016–e00016. 8 indexed citations
3.
Brenner, Darren M., Ronald Fogel, Spencer D. Dorn, et al.. (2018). Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials. The American Journal of Gastroenterology. 113(5). 735–745. 99 indexed citations
5.
Barish, Charles F. & Patrick Griffin. (2018). Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study. Current Medical Research and Opinion. 34(4). 751–755. 16 indexed citations
6.
Barish, Charles F., Robert A. Crozier, & Patrick Griffin. (2018). Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation. Current Medical Research and Opinion. 35(1). 81–85. 7 indexed citations
7.
Miner, Philip B., William Koltun, Gregory Wiener, et al.. (2017). A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation. The American Journal of Gastroenterology. 112(4). 613–621. 99 indexed citations
8.
Rao, Satish S.C., Patrick Griffin, & Leslie Magnus. (2017). Efficacy and Safety of Plecanatide in Patients with Chronic Idiopathic Constipation: An Analysis of Patients with Moderate to Very Severe Bloating. Gastroenterology. 152(5). S507–S507.
9.
DeMicco, Michael, et al.. (2017). Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation. Therapeutic Advances in Gastroenterology. 10(11). 837–851. 52 indexed citations
10.
Fogel, Ronald, Spencer D. Dorn, Richard A. Krause, et al.. (2017). Efficacy and Safety of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation: Results from 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Gastroenterology. 152(5). S1309–S1310. 6 indexed citations
11.
Krause, Richard A., et al.. (2016). Sa1444 Effect of Plecanatide on Stool Consistency in the Treatment of Chronic Idiopathic Constipation (CIC): Results from Two Phase III Studies. Gastroenterology. 150(4). S317–S318. 3 indexed citations
12.
Barrow, Laura, et al.. (2016). Safety and Tolerability of Plecanatide in Patients with Chronic Idiopathic Constipation: Long-term Evidence from an Open-Label Study. The American Journal of Gastroenterology. 111. S248–S249. 1 indexed citations
14.
O’Leary, Timothy J., et al.. (2015). Investigating Test User Interpretations and Actions Based on Score Reports. 1 indexed citations
15.
Miner, Philip B., Robert DeLuca, William Koltun, et al.. (2014). Plecanatide, a Novel Uroguanylin Analog: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate Efficacy and Safety in Patients With Irritable Bowel Syndrome With Constipation (IBS-C). The American Journal of Gastroenterology. 109. S541–S541. 29 indexed citations
16.
O’Connor, Katherine W., Gregory A. Boyce, William S. Brooks, et al.. (1993). The Recommended Use of Laboratory Studies Before Endoscopic Procedures. Gastrointestinal Endoscopy. 39(6). 892–894. 3 indexed citations
17.
Griffin, Patrick, et al.. (1986). Intramural Gastrointestinal Hemorrhage. Journal of Clinical Gastroenterology. 8(3 Part 2). 389–389. 8 indexed citations
18.
Chopra, Sanjiv & Patrick Griffin. (1985). Laboratory tests and diagnostic procedures in evaluation of liver disease. The American Journal of Medicine. 79(2). 221–230. 55 indexed citations
19.
Hutcheon, Michael, Patrick Griffin, Henry Levison, & Noé Zamel. (1974). A New Test in Detection of Mild Abnormalities of Lung Mechanics" 2. 11 indexed citations
20.
Griffin, Patrick, et al.. (1974). The Search for the Nile. The History Teacher. 7(2). 284–284. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026